angiotensin ii has been researched along with 3-iodobenzylguanidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, O; Ishikawa, J; Nawada, R; Obayashi, K; Sakata, K; Tamekiyo, H; Yoshida, H | 1 |
| Litchie, B; Storie, B; Thomas, S; Yau, L; Yurkova, N; Zahradka, P | 1 |
1 trial(s) available for angiotensin ii and 3-iodobenzylguanidine
| Article | Year |
|---|---|
Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Female; Heart; Hemodynamics; Humans; Hypertension; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Radionuclide Imaging; Radiopharmaceuticals; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrahydroisoquinolines; Treatment Outcome | 2002 |
1 other study(ies) available for angiotensin ii and 3-iodobenzylguanidine
| Article | Year |
|---|---|
Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression.
Topics: 3-Iodobenzylguanidine; Adenosine Diphosphate Ribose; ADP Ribose Transferases; Angiotensin II; Animals; Cell Division; Cell Movement; Cells, Cultured; Dinoprostone; DNA; Enzyme Inhibitors; Gene Expression; Isoquinolines; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Phosphatidylinositol 3-Kinases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase C; Proto-Oncogene Proteins c-fos; Signal Transduction | 2003 |